News | July 02, 2021
Sandu Pharmaceuticals Q4FY21 PAT at Rs. 46.14 lakhs
The company has posted net profit of Rs.1.09 crores for the 12 months period ended March 31, 2021
The company has posted net profit of Rs.1.09 crores for the 12 months period ended March 31, 2021
The company has reported total income of Rs.355.43 crores during FY 2020-21
The company has posted net profit of Rs.12.12 crores for the 12 months period ended March 31, 2021
The company is doubling its chemistry research capacity that should commission by Q2'FY22
The company has posted net profit of Rs.147.78 crores for the 12 months period ended March 31, 2021
It posted net profit of Rs.60.96 crores for the 12 months period ended March 31, 2021
The company has registered total income of Rs. 3,847 crores for Q4 FY21, up by 3% on a y-o-y basis from Rs. 3,752 crores registered during corresponding period of the previous year
Cadila Healthcare has reported total income of Rs.15139.4 crores FY 2020-21
Strides Pharma Science reported total income of Rs.3367.29 crores during FY 2020-21
It posted net profit of Rs.188.77 crores for the period ended March 31, 2020.
Subscribe To Our Newsletter & Stay Updated
